Torrent Pharmaceuticals — Q3 FY2018-19 Earnings Presentation

4 slides from Torrent Pharmaceuticals's earnings presentation, Jan 30, 2019

Slide 1: Exchange filing cover letter for analyst presentation
~;orrent- W PHRRmR 30th January, 2019 The Dy. General Manager (List,ing Dept.) The Manager- Listing Dept., BSE Limited., National Stock Exchange oflndia Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, For
Slide 2: Q3 & YTD Dec FY 2018-19
Q3 & Ytd Dec FY 2018-19 1
Slide 3: Consolidated Revenues for Q3 2018-19
Consolidated Revenues for Q3 2018-19 (` Crore) Particulars Q3 1819 Q3 1718 Gr% India (Incl Unichem) 835 586 42% US 490 266 84% Brazil 168 194 -13% Germany 267 227 18% Other 171 131 31% Others (Incl contract Mfg.) 120 59 103% Total 2,051 1,463 40% 2
Slide 4: Consolidated Revenues for YTD Dec FY 2018-19
Consolidated Revenues for YTD Dec FY 2018-19 (` Crore) Particulars YTD 1819 YTD 1718 Gr% India (Incl Unichem) 2,480 1,658 50% US 1,217 793 54% Brazil 483 495 -2% Germany 770 626 23% Other 500 389 28% Others (Incl contract Mfg.) 367 281 31% Total 5,817 4,242 37% 3